ReproNovo (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- May 22, 2025
- Vertical
- Reproductive Medicine
- Funding URL
- View Funding Page
- Funding Amount:
- $65,000,000
Company Info
- Founding Year
- 2021
- Traction
- ReproNovo has two drug candidates in clinical Phase 2 addressing three disease conditions.
- Founders
- Jean Marie Duvall, Dr. Joan-Carles Arce, BingMei Hao
- Company Description
- ReproNovo is a startup specializing in reproductive medicine and women's health, developing novel therapies for under-addressed indications including male and female infertility and uterine diseases.
- Market
- Women's Health
- Location
- Lausanne, Switzerland
- Coinvestors
- Jeito Capital, AXA IM Alts, M Ventures, Ysios Capital, ALSA Ventures